Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

cnbc.com/2025/06/23/novo-nordisk-ends-wegovy-deal-with-hims-hers.html

Novo Nordisk on Monday said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company's sales and promotion of cheaper knock-offs of the weight loss drug Wegovy.
Shares of Hims & Hers fell about 20% in premarket trading Monday.
Novo Nordisk in April…

This story appeared on cnbc.com, 2025-06-23 12:41:19.
The Entire Business World on a Single Page. Free to Use →